title: Methotrexate, homocysteine, and seizures.
authors.forename: C T
authors.initials: CT
authors.lastname: Quinn
authors.forename: J C
authors.initials: JC
authors.lastname: Griener
authors.forename: T
authors.initials: T
authors.lastname: Bottiglieri
authors.forename: B A
authors.initials: BA
authors.lastname: Kamen
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000134:cerebrospinal fluid; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003545:Cysteine / Q000031:analogs & derivatives / Q000134:cerebrospinal fluid; D004830:Epilepsy, Tonic-Clonic / Q000134:cerebrospinal fluid*; D006710:Homocysteine / Q000031:analogs & derivatives / Q000134:cerebrospinal fluid; D006801:Humans; D007223:Infant; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000134:cerebrospinal fluid; D018377:Neurotransmitter Agents; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000134:cerebrospinal fluid* / Q000188:drug therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D018377:Neurotransmitter Agents; D006710:Homocysteine; C007956:homocysteic acid; D003545:Cysteine; C013461:cysteine sulfinic acid; D008727:Methotrexate